Common side effects can include nausea, vomiting, diarrhea, constipation, stomach discomfort, bloating, and decreased appetite
GLP-1s are a specific type of medication first launched in 2005 for the treatment of type 2 diabetes
Traditional weight loss methods often focus solely on caloric restriction and exercise, which may not address underlying factors like hormonal imbalances or appetite control
Some report that lower doses, including approaches like low-dose semaglutide or semaglutide microdosing, feel easier to tolerate and less disruptive to daily routines, particularly early in treatment
These medications can also be beneficial for people with obesity or those who need help managing their weight due to other health conditions
In essence, GLP-1s are a toolnot a Swiss Army knife that can tackle every challengeand bistroMD can serve as another valuable instrument in your toolkit!